Cargando…

Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy

Dilated cardiomyopathy is an important cause of congestive cardiac failure in infants and children. Mobilizing hematopoietic progenitor cells is a promising intervention to this deadly disease. Aim. Evaluate granulocyte colony stimulating factor (GCSF) as therapeutic modality in children with idiopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habeeb, Nevin M., Youssef, Omneya I., El Hadidi, Eman S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485505/ https://www.ncbi.nlm.nih.gov/pubmed/23150834 http://dx.doi.org/10.5402/2012/927968

Ejemplares similares

Three Dimensional (3D) Echocardiography as a Tool of Left Ventricular Assessment in Children with Dilated Cardiomyopathy: Comparison to Cardiac MRI
por: Habeeb, Nevin Mohamed, et al.
Publicado: (2018)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy
por: Li, Jiangtao, et al.
Publicado: (2023)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy
por: Frljak, Sabina, et al.
Publicado: (2018)

The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Relationship between malnutrition and coronary microvascular dysfunction in patients with nonischemic dilated cardiomyopathy
por: KUL, Şeref, et al.
Publicado: (2020)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials
por: Tripathi, Avnish, et al.
Publicado: (2021)

Biventricular thrombi of nonischemic cardiomyopathy
por: Adnan, Mohammed Muqeet, et al.
Publicado: (2014)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022)

Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
por: Romuk, Ewa, et al.
Publicado: (2019)

Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
por: Khan, Safi U., et al.
Publicado: (2017)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
por: Domae, Keitaro, et al.
Publicado: (2021)

Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)

Profile of nonischemic dilated cardiomyopathy patients with long-term survival ≥10 years on medical therapy alone
por: Monga, Inderjeet S., et al.
Publicado: (2022)

Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
por: Cadour, Farah, et al.
Publicado: (2023)

T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy
por: Chang, Suyon, et al.
Publicado: (2023)

QTc and QTd in Children with Type 1 Diabetes Mellitus during Diabetic Ketoacidosis
por: Youssef, Omneya I., et al.
Publicado: (2012)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
por: Oladiran, Oreoluwa, et al.
Publicado: (2018)

Longitudinal strain with speckle-tracking echocardiography predicts electroanatomic substrate for ventricular tachycardia in nonischemic cardiomyopathy patients
por: Trivedi, Siddharth J., et al.
Publicado: (2022)

Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
por: Yang, Sirui, et al.
Publicado: (2013)

Antifailure Therapy Including Spironolactone Improves Left Ventricular Energy Supply‐Demand Relations in Nonischemic Dilated Cardiomyopathy
por: Bell, Susan P., et al.
Publicado: (2014)

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
por: Lin, Fang, et al.
Publicado: (2019)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
por: Kim, Hyue-Mee, et al.
Publicado: (2021)

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
por: Huang, Guangyong, et al.
Publicado: (2021)

Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)

Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?
por: Kotby, Alyaa A., et al.
Publicado: (2013)

Diagnostic Value of Exhaled Carbon Monoxide as an Early Marker of Exacerbation in Children with Chronic Lung Diseases
por: Abd EL Khalek, Karima A., et al.
Publicado: (2012)

Cardiomyocyte Regeneration in the mdx Mouse Model of Nonischemic Cardiomyopathy
por: Richardson, Gavin David, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kp7jm2vm532adg0tkc440i0c1s